S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Cardiome Pharma (CRME) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
nasdaq.com logoAmphastar Pharmaceuticals (FRA:29A) Price Target Increased by 46.10% to 60.45
nasdaq.com - August 13 at 8:50 PM
marketwatch.com logoExpert Analysis on Pharmaceutical Rubber Stoppers Market by 2023-2030
marketwatch.com - March 25 at 7:37 AM
msn.com logoGlenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mg
msn.com - February 17 at 1:50 AM
msn.com logoPharmacy Career Conference returned in its 4th edition to assist and inspire pharmacy students and industry professionals
msn.com - February 12 at 4:32 AM
msn.com logoPharma sector growth healthy after Covid too
msn.com - February 1 at 6:39 AM
cbsnews.com logoDOJ sues pharma giant AmerisourceBergen Corp. for allegedly helping to fuel the opioid epidemic
cbsnews.com - December 29 at 3:02 PM
marketwatch.com logoAcute Coronary Syndrome Therapeutics Market Size in Pharma & Healthcare Sector is Growing Quickly with Analysis by Top Key players till 2028
marketwatch.com - November 2 at 6:25 PM
yahoo.com logoPharmaceutical Fine Chemicals Category Is Projected to Grow at a CAGR of 5.86% by 2026, SpendEdge Reports
yahoo.com - October 20 at 9:08 PM
finance.yahoo.com logoJenny Sundqvist new CEO of InDex Pharmaceuticals
finance.yahoo.com - October 13 at 3:12 PM
benzinga.com logo1SOMAÍ Pharmaceuticals Opens Medical Cannabis Manufacturing Facility In Portugal
benzinga.com - September 28 at 11:36 PM
msn.com logoNLEM 2022 | Govt releases new list of 384 essential medicines; 34 drugs added, 26 dropped
msn.com - September 13 at 4:42 PM
msn.com logoMacleods Pharmaceuticals defers big-bang listing plans; will PE funds step in now?
msn.com - September 13 at 11:41 AM
marketwatch.com logoCardiac Rhythm Management Devices Market [4.5% CAGR] 2022 Industry Research Analysis Opportunities Key Players Analysis And Forecast By 2028
marketwatch.com - August 30 at 6:44 PM
finance.yahoo.com logoCardiome Pharma Corp. Announces Approximately US$15.0 Million Bought Deal Financing
finance.yahoo.com - October 26 at 11:15 AM
Get Cardiome Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRME and its competitors with MarketBeat's FREE daily newsletter.

Don’t expose yourself to stocks during the week (Ad)

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

CRME Media Mentions By Week

CRME Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRME
News Sentiment

0.00

0.51

Average
Medical
News Sentiment

CRME News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRME Articles
This Week

0

0

CRME Articles
Average Week

Get Cardiome Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRME and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CRME) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners